Global Healthcare Regulation Will Squeeze Margins Amid Rising Costs
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 13 Analysts
Published
07 Jul 25
Updated
20 Aug 25
AnalystLowTarget's Fair Value
₹303.09
190.0% overvalued intrinsic discount20 Aug
₹879.10
1Y
97.0%7D
2.3%